Почетна › Акутна миелоидна леукемија › Њу Џерси › Edison
Клинички испитувања за Акутна миелоидна леукемија во Edison, NJ
20 студии за Акутна миелоидна леукемија бараат учесници на локации во и околу Edison (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Се регрутираФаза 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Се регрутираФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
A Study of CRD3874-SI in People With Leukemia
Се регрутираФаза 1
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Се регрутираФаза 3
- Saint Peter's University Hospital, New Brunswick · на 3 милји
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · на 3 милји
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Се регрутираФаза 1/2
- Saint Peter's University Hospital, New Brunswick · на 3 милји
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · на 3 милји
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Се регрутираФаза 3
- Rutgers Biomedical and Health Sciences, New Brunswick · на 3 милји
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Се регрутираФаза 2
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Се регрутираНабљудувачка студија
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · на 3 милји
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Се регрутираФаза 1
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Се регрутираФаза 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
A Study of Revumenib and Mezigdomide in People With Leukemia
Се регрутираФаза 1/2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Се регрутираФаза 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Се регрутираФаза 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Се регрутираФаза 1
- Rutgers Cancer Institute, New Brunswick · на 3 милји
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Се регрутираФаза 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Се регрутираФаза 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Испитувања за Акутна миелоидна леукемија во други градови
- Houston, TX85 студии
- New York City, NY51 студија
- Boston, MA44 студии
- Baldwin Park, CA40 студии
- Seattle, WA40 студии
- Columbus, OH35 студии
- Philadelphia, PA34 студии
- Durham, NC33 студии
- Atlanta, GA30 студии
- Tampa, FL29 студии
- Chicago, IL26 студии
- Portland, OR25 студии
Други студии во Edison
- Рак на дојка68 студии
- Рак на бели дробови со не-мали клетки47 студии
- Рак (сите типови)33 студии
- Рак на простата29 студии
- Колоректален карцином23 студии
- Рак на бели дробови23 студии
- Множен миелом22 студии
- Рак на бешиката21 студија
- Метастатски карцином20 студии
- Карцином на јајниците20 студии
- Рак на ендометриумот19 студии
- Уротелен (транзицисно клеточен) карцином18 студии
Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.